Investigating the solubilization effect of oxcarbazepine by forming cocrystals
Oxcarbazepine (OXCBZ) is a poorly soluble drug that can't form a salt. It has an amide functional group and a carbonyl group in its structure, which can be used to form cocrystals. Three cocrystals of OXCBZ were successfully synthesized through liquid-assisted grinding and reaction crystallizat...
Saved in:
Published in | CrystEngComm Vol. 21; no. 32; pp. 4718 - 4729 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Cambridge
Royal Society of Chemistry
2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Oxcarbazepine (OXCBZ) is a poorly soluble drug that can't form a salt. It has an amide functional group and a carbonyl group in its structure, which can be used to form cocrystals. Three cocrystals of OXCBZ were successfully synthesized through liquid-assisted grinding and reaction crystallization. Since OXCBZ has an amide group and a keto group, oxalic acid (OA), 2,5-dihydroxybenzoic acid (2,5-DHBA), and salicylic acid (SA) were selected as coformers which can form a hydrogen bond with an amide group or a keto group. The formation of OXCBZ cocrystals was confirmed by characterization
via
powder X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, Fourier transform infrared spectroscopy, scanning electron microscopy, and solid state nuclear magnetic resonance spectroscopy. Effects of different conditions on the preparation of the cocrystal were investigated to optimize the cocrystal preparation process. The apparent solubility and dissolution rate of the cocrystals were investigated too. The apparent solubility of the OXCBZ-OA and OXCBZ-2,5-DHBA cocrystals increased approximately 2.6 and 4.7 times that of the pure drug.
Oxcarbazepine (OXCBZ) is a poorly soluble drug that can't form a salt. The apparent solubilities of the OXCBZ-OA and OXCBZ-2,5-DHBA cocrystals increased approximately 2.6 and 4.7 times of that of OXCBZ. |
---|---|
Bibliography: | Electronic supplementary information (ESI) available. See DOI 10.1039/c9ce00651f |
ISSN: | 1466-8033 1466-8033 |
DOI: | 10.1039/c9ce00651f |